182 related articles for article (PubMed ID: 4599330)
61. Tumor-associated antigens in human malignant melanoma.
Lewis MG; Avis PJ; Phillips TM; Sheikh KM
Yale J Biol Med; 1973 Dec; 46(5):661-8. PubMed ID: 4591789
[No Abstract] [Full Text] [Related]
62. Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma.
Abel EA; Bystryn JC
J Invest Dermatol; 1976 Jan; 66(1):44-8. PubMed ID: 1107434
[TBL] [Abstract][Full Text] [Related]
63. Immune reactions in chronic myeloid leukaemia.
Danieli G; Montroni M; Magelli L
Haematologica; 1972 Apr; 57(11):697-707. PubMed ID: 4200304
[No Abstract] [Full Text] [Related]
64. [Immunology of malignant melanomas].
Schieferstein G
Fortschr Med; 1976 May; 94(14):833-7. PubMed ID: 1270047
[TBL] [Abstract][Full Text] [Related]
65. [Modifications of B lymphocyte membrane markers in patients with osteosarcoma].
Torelli L; Marinoni I
Boll Ist Sieroter Milan; 1976; 55(6):553-9. PubMed ID: 798595
[TBL] [Abstract][Full Text] [Related]
66. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
Jehn UW; Nathanson L; Schwartz RS; Skinner M
N Engl J Med; 1970 Aug; 283(7):329-33. PubMed ID: 4193645
[No Abstract] [Full Text] [Related]
67. [Immunofluorescent phenomena in malignant melanoma].
Misgeld V; Meisel C
Arch Dermatol Forsch; 1972; 244():605-6. PubMed ID: 4567634
[No Abstract] [Full Text] [Related]
68. Humoral immunity in malignant skin melanoma. Isolation of melanoma specific IgG from melanoma metastases.
Kristensen E; Langvad E; Reimann R
Eur J Cancer (1965); 1976 Dec; 12(12):945-50. PubMed ID: 1009994
[No Abstract] [Full Text] [Related]
69. Reduced lymphocyte subpopulations in patients with advanced or disseminated melanoma.
Cartei G; Sala PG; Sanzari M; Ceschia V; Clocchiatti L; Sibau A; Donà S; Giovannoni M; Vigevani E
J Am Acad Dermatol; 1993 May; 28(5 Pt 1):738-44. PubMed ID: 8496418
[TBL] [Abstract][Full Text] [Related]
70. Report of the immunology working party of the EORTC melanoma group.
Rümke P
Eur J Cancer Clin Oncol; 1981 Jul; 17(7):839-41. PubMed ID: 7037425
[No Abstract] [Full Text] [Related]
71. Immunologic changes in regional lymph nodes of melanoma patients.
Hammer C; Lewis MG; Rowden G; Phillips T
Chir Forum Exp Klin Forsch; 1978; (1978):235-8. PubMed ID: 313322
[TBL] [Abstract][Full Text] [Related]
72. [Specific immune reactivity in patients with malignant melanoma (author's transl)].
Poljak-Blazi M; Montani D; Ferle-Vidović A; Boranić M
Lijec Vjesn; 1977 Dec; 99(12):735-8. PubMed ID: 607047
[No Abstract] [Full Text] [Related]
73. Melanoma-associated antigens: prospects for clinical use.
Lejeune FJ; Libert A
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1433-8. PubMed ID: 3830723
[No Abstract] [Full Text] [Related]
74. Presence and possible role of anti-IgG antibodies in human malignancy.
Hartmann D; Lewis MG
Lancet; 1974 Jun; 1(7870):1318-20. PubMed ID: 4134298
[No Abstract] [Full Text] [Related]
75. In-vitro interactions between antitumour antibodies and anti-antibodies in malignancy.
Hartmann D; Lewis MG; Proctor JW; Lyons H
Lancet; 1974 Dec; 2(7895):1481-3. PubMed ID: 4140396
[No Abstract] [Full Text] [Related]
76. Auto-antibodies in malignant disease.
Whitehouse JM; Fairley G
Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):197-202. PubMed ID: 4589246
[No Abstract] [Full Text] [Related]
77. [Value of thymodependant rosette tests in the surveillance of malignant melanoma. Preliminary study apropos of 25 cases].
Claudy A; Fouad-Wassef N; Pelletier N
Ann Dermatol Syphiligr (Paris); 1975; 102(1):69-70. PubMed ID: 1084114
[No Abstract] [Full Text] [Related]
78. Antibodies and antigen expression in human melanoma detected by the immune adherence test.
Cornain S; de Vries JE; Collard J; Vennegoor C; van Wingerden I; Rümke P
Int J Cancer; 1975 Dec; 16(6):981-97. PubMed ID: 1104492
[TBL] [Abstract][Full Text] [Related]
79. Current concepts of the biology of human cutaneous malignant melanoma.
Clark WH; Mastrangelo MJ; Ainsworth AM; Berd D; Bellet RE; Bernardino EA
Adv Cancer Res; 1977; 24():267-338. PubMed ID: 322460
[No Abstract] [Full Text] [Related]
80. [IgG, IgM and IgA levels and presence of antinuclear factors and antibodies to smooth muscles in patients with malignant melanoma].
Jassem J; Moszkowska G; Młodkowska A; Jaśkiewicz J
Pol Tyg Lek; 1979 May; 34(21):813-6. PubMed ID: 314107
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
